Le Lézard
Classified in: Health
Subject: RCL

Food Recall Warning - Igor brand Gorgonzola Dolce recalled due to Listeria monocytogenes


Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/igor-brand-gorgonzola-dolce-recalled-due-listeria-monocytogenes

OTTAWA, ON, Dec. 16, 2022 /CNW/ -

Summary
Affected products

Brand

Product

Size

UPC

Codes

Igor

Gorgonzola Dolce

Variable

Variable

Best Before:

23/FE/01

Lotto 2774015

and

23/FE/01

Lotto 2775033

Issue

The affected product is being recalled from the marketplace due to possible Listeria contamination.

The recalled product may have been sold by various retailers, either clerk-served or in smaller packages, with or without a label that may not bear the same brand, product name or best before date.  Consumers who are unsure if they have purchased the recalled product are advised to contact their retailer.

The recalled product has been sold in British Columbia, Ontario, and Quebec and may have been distributed in other provinces and territories.  

What you should do

Food contaminated with Listeria monocytogenes may not look or smell spoiled but can still make you sick. Symptoms can include vomiting, nausea, persistent fever, muscle aches, severe headache and neck stiffness. Pregnant women, the elderly and people with weakened immune systems are particularly at risk. Although infected pregnant women may experience only mild, flu-like symptoms, the infection can lead to premature delivery, infection of the newborn or even stillbirth. In severe cases of illness, people may die.

Learn more:

Background

This recall was triggered by Canadian Food Inspection Agency test results.

There have been no reported illnesses associated with the consumption of this product.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 07:30
The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, will host its VISIONS 2024 conference at the Chicago Marriott Downtown Magnificent Mile on June 21?22, 2024. This biennial...

at 07:30
Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new groundbreaking algorithm, SignalHF1, used...

at 07:30
The American Trucking Associations is calling attention to the negative consequences for highway safety and safety-sensitive industries that could result from the U.S. Drug Enforcement Administration's proposal to reschedule marijuana from a Schedule...

at 07:30
-    AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)-    Data to be presented from...

at 07:28
We are advised by OsteoStrong that journalists and other readers should disregard the news release, OsteoStrong Celebrates Success and Innovation at 11th Annual Global Franchise Owner Convention, issued May 9, 2024 over PR Newswire. SOURCE...

at 07:05
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today...



News published on and distributed by: